✦ LIBER ✦

Non-cognitive outcomes in trials of disease-modifying drugs for Alzheimer's disease

✍ Scribed by D. Zekry; C.E. Graf; S.V. Giannelli; G. Gold; J.-P. Michel

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Imaging-Based Measures of Disease Progre

✍ Matthews, Brandy; Siemers, Eric R.; Mozley, P. David 📂 Article 📅 2003 🏛 American Psychiatric Publishing Inc 🌐 English ⚖ 488 KB

Neuroimaging biomarkers for clinical tri

✍ Dickerson, Bradford C. ;Sperling, Reisa A. 📂 Article 📅 2005 🏛 American Society for Experimental NeuroTherapeutic 🌐 English ⚖ 273 KB

IN54-TH-03 Disease-modifying drugs and v

✍ J. Cummings 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 45 KB

Disease-modifying trials in Alzheimer's

✍ Bruno Vellas; Sandrine Andrieu; Cristina Sampaio; Gordon Wilcock 📂 Article 📅 2007 🏛 The Lancet 🌐 English ⚖ 94 KB

Challenges to demonstrating disease-modi

✍ Jeffrey L. Cummings 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 229 KB

Preventive Drug trials for Alzheimer's d

✍ Vellas, Bruno 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 64 KB